| Most influenza a virions fail to express at least one essential viral protein CB Brooke, WL Ince, J Wrammert, R Ahmed, PC Wilson, JR Bennink, ... Journal of virology 87 (6), 3155-3162, 2013 | 221 | 2013 |
| Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 N Drayman, JK DeMarco, KA Jones, SA Azizi, HM Froggatt, K Tan, ... Science 373 (6557), 931-936, 2021 | 135 | 2021 |
| Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection RL Smith, LL Gibson, PP Martinez, R Ke, A Mirza, M Conte, N Gallagher, ... The Journal of infectious diseases 224 (6), 976-982, 2021 | 126 | 2021 |
| Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection SR Das, SE Hensley, WL Ince, CB Brooke, A Subba, MG Delboy, G Russ, ... Cell host & microbe 13 (3), 314-323, 2013 | 111 | 2013 |
| Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke, ... biorxiv, 2020.06. 18.159434, 2020 | 108 | 2020 |
| Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells W Hou, JS Gibbs, X Lu, CB Brooke, D Roy, RL Modlin, JR Bennink, ... Blood, The Journal of the American Society of Hematology 119 (13), 3128-3131, 2012 | 104 | 2012 |
| Biological activities of'noninfectious' influenza A virus particles CB Brooke Future virology 9 (1), 41-51, 2014 | 93 | 2014 |
| Population diversity and collective interactions during influenza virus infection CB Brooke Journal of Virology 91 (22), e01164-17, 2017 | 88 | 2017 |
| Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs I Kosik, WL Ince, LE Gentles, AJ Oler, M Kosikova, M Angel, JG Magadán, ... PLoS pathogens 14 (1), e1006796, 2018 | 69 | 2018 |
| Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility CB Brooke, WL Ince, J Wei, JR Bennink, JW Yewdell Proceedings of the National Academy of Sciences 111 (47), 16854-16859, 2014 | 64 | 2014 |
| Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveals limited infectious virus shedding and restricted tissue distribution R Ke, PP Martinez, RL Smith, LL Gibson, CJ Achenbach, S McFall, C Qi, ... Open forum infectious diseases 9 (7), ofac192, 2022 | 61 | 2022 |
| Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness R Ke, PP Martinez, RL Smith, LL Gibson, A Mirza, M Conte, N Gallagher, ... Nature Microbiology 7 (5), 640-652, 2022 | 60 | 2022 |
| Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies I Kosik, D Angeletti, JS Gibbs, M Angel, K Takeda, M Kosikova, V Nair, ... Journal of Experimental Medicine 216 (2), 304-316, 2019 | 60 | 2019 |
| Causes and consequences of spatial within-host viral spread ME Gallagher, CB Brooke, R Ke, K Koelle Viruses 10 (11), 627, 2018 | 54 | 2018 |
| The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection A Schafer, CB Brooke, AC Whitmore, RE Johnston Journal of virology 85 (20), 2011 | 48 | 2011 |
| T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody CB Brooke, DJ Deming, AC Whitmore, LJ White, RE Johnston Journal of virology 84 (9), 4556-4568, 2010 | 46 | 2010 |
| Sequencing framework for the sensitive detection and precise mapping of defective interfering particle-associated deletions across influenza A and B viruses FG Alnaji, JR Holmes, G Rendon, JC Vera, CJ Fields, BE Martin, ... Journal of virology 93 (11), e00354-19, 2019 | 43 | 2019 |
| Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro N Drayman, KA Jones, SA Azizi, HM Froggatt, K Tan, NI Maltseva, S Chen, ... BioRxiv, 2020.08. 31.274639, 2020 | 40 | 2020 |
| Single cell heterogeneity in influenza A virus gene expression shapes the innate antiviral response to infection J Sun, JC Vera, J Drnevich, YT Lin, R Ke, CB Brooke PLoS pathogens 16 (7), e1008671, 2020 | 40 | 2020 |
| Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain TJC Tan, M Yuan, K Kuzelka, GC Padron, JR Beal, X Chen, Y Wang, ... Nature Communications 12 (1), 3815, 2021 | 37 | 2021 |
